Community News

The client specializes in high-resolution detection of small target gene panels. Recently, the client acquired a complementary technology to offer high-throughput detection of genes with their platform.

You will be working with an early-stage startup founded by Caltech scientists, whose long-term vision is to become the standard of care for IVF. The founders’ mission is to improve the embryo selection process through a new embryo evaluation technology and to eventually enable embryo-rescuing interventions through early detection of poor outcomes. You and the BCBA team will help set the company’s directions by helping them craft their business plan and prepare to raise their Series A funding.

Who we are: BCBA connects academic science trainees and recent graduates to the Bay Area’s biotech industry through hands-on consulting and due diligence projects. We are a volunteer organization composed of PhD students, post-docs, medical trainees, and young professionals looking to gain professional development skills for jobs in biotech companies, consulting, and venture capital. Over […]

Who we are: BCBA connects academic science trainees and recent graduates to the Bay Area’s biotech industry through hands-on consulting and due diligence projects. We are a volunteer organization composed of PhD students, post-docs, medical trainees, and young professionals looking to gain professional development skills for jobs in biotech companies, consulting, and venture capital. Over […]

The multi-institutional project team will perform due diligence on life science and therapeutics startups under consideration by venture capital firms in the Bay Area. For each company, the team may evaluate the following key areas: 1) company capabilities (e.g. scientific merit, intellectual property, etc.), 2) market attractiveness, and 3) competitive landscape. Team members will interact […]

As advances in medicine and technology have enabled societies to enjoy longer lifespans, increasing numbers of people will live to experience the negative effects age-associated diseases. An early-stage therapeutics company has engaged BCBA to identify appropriate molecular targets to combat age-associated diseases using high-throughput, high-dimensional approaches. Specifically, the BCBA team will use primary and secondary […]

An early-stage contract research organization (CRO) is providing high-throughput molecular structure determination services using a cutting-edge platform, enabling them to determine structures cheaper and more quickly than many competitors. The company believes that these advantages will enable them to capture a significant proportion of the molecular structure determination market, and that a large market opportunity […]

An early-stage biotechnology company with expertise in antibody therapeutics development is engaging BCBA to explore the GPCR-targeted therapeutics market. To that end, the BCBA project team will 1) conduct a comprehensive market landscape analysis of the GPCR therapeutic market to understand the market conditions and requirements for the development of compelling Proof-of-Concept (POC) programs in […]

The multi-institutional project team will perform due diligence on life science and therapeutics startups under consideration by venture capital firms in the Bay Area. For each company, the team may evaluate the following key areas: 1) company capabilities (e.g. scientific merit, intellectual property, etc.), 2) market attractiveness, and 3) competitive landscape. Team members will interact […]

An early-stage product company is developing smart solutions for whole-room health. The company has developed a light that emits in the far-UVC range, which has been shown to kill many pathogens and strongly indicated to be completely harmless to humans. This technology has the potential to revolutionize public health and greatly reduce the transmission of […]